Novel molecular typing reveals the risk of recurrence in patients with early-stage papillary thyroid cancer.

Mingyu SunBingqing ZhaoTao ChenLijun YaoXiaoxin LiShaojun HuChengling ChenXinbao GaoChuangang Tang

Published in: Thyroid research (2024)

These findings could help accurately and reliably identify PTC patients with high risk of recurrence so that they could receive more radical and aggressive treatment strategies and more rigorous surveillance practices.

Keyphrases

papillary thyroid
early stage
lymph node metastasis
free survival
primary care
healthcare
public health
radiation therapy
genetic diversity